Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
EU Delays Mercosur Free Trade Agreement Signing Amid Ukraine War Funding Talks 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
U.S. Dollar Steadies Near October Lows as Rate Cut Expectations Keep Markets on Edge 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Kevin Hassett Says Inflation Is Below Target, Backs Trump’s Call for Rate Cuts 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Precious Metals Rally as Silver and Platinum Outperform on Rate Cut Bets 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
U.S. Stock Futures Slip After CPI-Fueled Rally as Markets Weigh Economic Uncertainty 
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey 
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
